3,450 Shares of Danaher Corporation $DHR Acquired by Financial Planning Hawaii Inc.

by · The Markets Daily

Financial Planning Hawaii Inc. bought a new stake in shares of Danaher Corporation (NYSE:DHR – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 3,450 shares of the conglomerate’s stock, valued at approximately $764,000.

Several other hedge funds and other institutional investors also recently modified their holdings of DHR. Main Street Group LTD bought a new position in Danaher in the first quarter worth about $25,000. N.E.W. Advisory Services LLC bought a new stake in Danaher during the 2nd quarter valued at approximately $25,000. Marquette Asset Management LLC grew its holdings in shares of Danaher by 192.1% during the 3rd quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate’s stock worth $25,000 after acquiring an additional 73 shares during the period. Evolution Wealth Management Inc. grew its holdings in shares of Danaher by 208.0% during the 1st quarter. Evolution Wealth Management Inc. now owns 154 shares of the conglomerate’s stock worth $29,000 after acquiring an additional 104 shares during the period. Finally, Field & Main Bank bought a new position in shares of Danaher in the 2nd quarter worth approximately $29,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 0.9%

Shares of Danaher stock traded up $2.10 on Tuesday, reaching $223.30. The company’s stock had a trading volume of 6,007,508 shares, compared to its average volume of 4,462,041. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The firm’s fifty day simple moving average is $211.85 and its two-hundred day simple moving average is $194.88. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The company has a market capitalization of $156.98 billion, a price-to-earnings ratio of 39.66, a P/E/G ratio of 2.74 and a beta of 0.76.

Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%. The firm had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. During the same period in the prior year, the company posted $0.77 earnings per share. The company’s quarterly revenue was up 5.5% on a year-over-year basis. Equities analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be given a $0.40 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. Danaher’s payout ratio is 28.42%.

Analysts Set New Price Targets

DHR has been the subject of a number of research analyst reports. UBS Group started coverage on Danaher in a research note on Wednesday, September 9th. They issued a “buy” rating and a $250.00 target price for the company. The Goldman Sachs Group upped their price target on Danaher from $210.00 to $250.00 and gave the stock a “buy” rating in a research note on Monday, September 21st. Barclays increased their price objective on Danaher from $230.00 to $255.00 and gave the stock an “overweight” rating in a report on Wednesday, October 7th. Guggenheim raised their price objective on Danaher from $200.00 to $250.00 and gave the company a “buy” rating in a research report on Thursday, October 1st. Finally, Royal Bank Of Canada boosted their target price on shares of Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a report on Monday, October 5th. Two analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $235.41.

Read Our Latest Report on DHR

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.

Featured Stories